KIDNEY TRANSPLANT REJECTION
Clinical trials for KIDNEY TRANSPLANT REJECTION explained in plain language.
Never miss a new study
Get alerted when new KIDNEY TRANSPLANT REJECTION trials appear
Sign up with your email to follow new studies for KIDNEY TRANSPLANT REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kidney transplant patients: drug may replace standard Anti-Rejection meds
Disease control CompletedThis study tested a new drug called tegoprubart in 127 people receiving their first kidney transplant. The goal was to see if it works better than the standard drug tacrolimus at preventing organ rejection while causing fewer side effects like diabetes. Participants received eith…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Phase: PHASE2 • Sponsor: Eledon Pharmaceuticals • Aim: Disease control
Last updated Jun 16, 2026 12:51 UTC
-
Harmless virus may predict transplant trouble
Knowledge-focused CompletedThis study looked at 172 kidney transplant recipients to see if levels of a common, harmless virus (Torque Teno Virus) in the blood can predict serious infections or organ rejection. Participants were on stable immunosuppression for at least 3 months and were monitored for a year…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Sponsor: Singapore General Hospital • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:02 UTC